These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29477291)

  • 1. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group.
    Vargo JA; Moiseenko V; Grimm J; Caudell J; Clump DA; Yorke E; Xue J; Vinogradskiy Y; Moros EG; Mavroidis P; Jain S; El Naqa I; Marks LB; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):137-146. PubMed ID: 29477291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review.
    Lee J; Kim WC; Yoon WS; Koom WS; Rim CH
    Oral Oncol; 2020 Aug; 107():104757. PubMed ID: 32388412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2
    von der Grün J; Köhn J; Loutfi-Krauss B; Blanck O; Rödel C; Balermpas P
    Head Neck; 2019 Apr; 41(4):E48-E54. PubMed ID: 30521102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.
    Chen YJ; Kuo JV; Ramsinghani NS; Al-Ghazi MS
    Med Dosim; 2002; 27(2):171-6. PubMed ID: 12074469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
    Diao K; Nguyen TP; Moreno AC; Reddy JP; Garden AS; Wang CH; Tung S; Wang C; Wang XA; Rosenthal DI; Fuller CD; Gunn GB; Frank SJ; Morrison WH; Shah SJ; Lee A; Spiotto MT; Su SY; Ferrarotto R; Phan J
    Head Neck; 2021 Nov; 43(11):3331-3344. PubMed ID: 34269492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
    Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
    Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
    Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer.
    Stanisce L; Koshkareva Y; Xu Q; Patel A; Squillante C; Ahmad N; Rajagopalan K; Kubicek GJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818780086. PubMed ID: 29890894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
    Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma.
    Quan K; Xu KM; Zhang Y; Clump DA; Flickinger JC; Lalonde R; Burton SA; Heron DE
    Semin Radiat Oncol; 2016 Apr; 26(2):112-9. PubMed ID: 27000507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck.
    Vargo JA; Wegner RE; Heron DE; Ferris RL; Rwigema JC; Quinn A; Gigliotti P; Ohr J; Kubicek GJ; Burton S
    Head Neck; 2012 Aug; 34(8):1153-61. PubMed ID: 22076812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Ling DC; Vargo JA; Ferris RL; Ohr J; Clump DA; Yau WW; Duvvuri U; Kim S; Johnson JT; Bauman JE; Branstetter BF; Heron DE
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):973-980. PubMed ID: 27302512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
    Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
    Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.